Leukemia & Lymphoma Society - Mid-Atlantic

Volunteers are our partners in the crusade to end cancer and provide more options and a better life for patients and their families.

The mission of LLS is to cure leukemia, lymphoma, Hodgkin’s disease and myeloma and improve the quality of life of patients and their families.

• LLS has invested more than $1.5 Billion in cutting edge research since 1949 to save lives of blood cancer patients. Because there is no way to prevent or screen for most blood cancers, LLS is focused on finding cures.
• In 2021, LLS helped advance nearly half of blood cancer treatment options approved by the FDA.
• Over the last 5 years, LLS helped advance more than 75% of the almost 100 FDA-approved blood cancer treatment options. We are the leaders in advancing breakthroughs in immunotherapy, genomics and personalized medicine.
• LLS funded research has led to new treatments that are being applied in other types of cancer including bone, brain, breast, kidney, liver, lung, ovarian, pancreatic and stomach.